Martin Marietta Materials, Inc. (BMV:MLM)

Ligand Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	6,685	6,536	6,777	6,161	5,414	4,432
Revenue Growth (YoY)	1.03%	-3.56%	10.00%	13.80%	22.15%	0.22%
Cost of Revenue	4,698	4,638	4,754	4,738	4,066	3,176
Gross Profit	1,987	1,898	2,023	1,423	1,348	1,257
Selling, General & Admin	434	431	430	374	329.2	302.1
Other Operating Expenses	2	-17	-8	-38	-12.7	13.8
Operating Expenses	436	414	422	336	316.5	315.9
Operating Income	1,551	1,484	1,601	1,087	1,032	940.6
Interest Expense	-203	-169	-165	-169	-142.7	-118.1
Interest & Investment Income	40	40	47	14	-	-
Other Non Operating Income (Expenses)	-24	2	2	4	2.6	-1.8
EBT Excluding Unusual Items	1,364	1,357	1,485	936	891.8	820.7
Merger & Restructuring Charges	-33	-120	-12	-9	-57.9	-1.3
Gain (Loss) on Sale of Assets	38	1,359	20	152	21.6	69.9
Other Unusual Items	-	-	-	12	-	-
Pretax Income	1,369	2,596	1,493	1,091	855.5	889.3
Income Tax Expense	269	600	293	235	153.2	168.2
Earnings From Continuing Operations	1,100	1,996	1,200	856	702.3	721.1
Earnings From Discontinued Operations	-	-	-30	11	0.5	-
Net Income to Company	1,100	1,996	1,170	867	702.8	721.1
Minority Interest in Earnings	-	-1	-1	-	-0.3	-0.1
Net Income	1,100	1,995	1,169	867	702.5	721
Preferred Dividends & Other Adjustments	-	-	-	-	0.2	0.6
Net Income to Common	1,100	1,995	1,169	867	702.3	720.4
Net Income Growth	-46.05%	70.66%	34.83%	23.42%	-2.57%	17.83%
Shares Outstanding (Basic)	61	61	62	62	62	62
Shares Outstanding (Diluted)	61	62	62	63	63	62
Shares Change (YoY)	-1.37%	-0.80%	-0.64%	-0.16%	0.32%	-0.48%
EPS (Basic)	18.06	32.49	18.89	13.92	11.25	11.56
EPS (Diluted)	18.04	32.41	18.84	13.88	11.22	11.54
EPS Growth	-45.19%	72.06%	35.75%	23.69%	-2.79%	18.48%
Free Cash Flow	963	604	878	509	714.6	690.4
Free Cash Flow Per Share	15.77	9.80	14.14	8.14	11.41	11.06
Dividend Per Share	3.160	3.060	2.800	2.540	2.360	2.240
Dividend Growth	6.76%	9.29%	10.24%	7.63%	5.36%	8.74%
Gross Margin	29.72%	29.04%	29.85%	23.10%	24.91%	28.35%
Operating Margin	23.20%	22.71%	23.62%	17.64%	19.06%	21.22%
Profit Margin	16.46%	30.52%	17.25%	14.07%	12.97%	16.25%
Free Cash Flow Margin	14.41%	9.24%	12.96%	8.26%	13.20%	15.58%
EBITDA	2,173	2,057	2,114	1,593	1,484	1,334
EBITDA Margin	32.51%	31.47%	31.19%	25.86%	27.40%	30.10%
D&A For EBITDA	622	573	513	506	451.7	393.5
EBIT	1,551	1,484	1,601	1,087	1,032	940.6
EBIT Margin	23.20%	22.71%	23.62%	17.64%	19.06%	21.22%
Effective Tax Rate	19.65%	23.11%	19.63%	21.54%	17.91%	18.91%
Revenue as Reported	-	-	-	-	-	4,730

Source: S&P Global Market Intelligence. Standard template. Financial Sources.